Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 28373299)

Published in Genome Res on April 01, 2017

Authors

Winnie S Liang1, William Hendricks1, Jeffrey Kiefer1, Jessica Schmidt2, Shobana Sekar1, John Carpten1, David W Craig1, Jonathan Adkins1, Lori Cuyugan1, Zarko Manojlovic1, Rebecca F Halperin1, Adrienne Helland1, Sara Nasser1, Christophe Legendre1, Laurence H Hurley3, Karthigayini Sivaprakasam1, Douglas B Johnson4, Holly Crandall4, Klaus J Busam5, Victoria Zismann1, Valerie Deluca1, Jeeyun Lee6, Aleksandar Sekulic1,2, Charlotte E Ariyan5, Jeffrey Sosman7, Jeffrey Trent1

Author Affiliations

1: Translational Genomics Research Institute, Phoenix, Arizona 85004, USA.
2: Mayo Clinic, Scottsdale, Arizona 85259, USA.
3: University of Arizona, College of Pharmacy, Tucson, Arizona 85721, USA.
4: Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.
5: Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
6: Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, Korea.
7: Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois 60611, USA.

Articles cited by this

Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (2009) 190.94

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol (2010) 75.21

Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 28.20

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol (2014) 27.48

STAR: ultrafast universal RNA-seq aligner. Bioinformatics (2012) 25.21

Signatures of mutational processes in human cancer. Nature (2013) 21.63

Distinct sets of genetic alterations in melanoma. N Engl J Med (2005) 17.26

Genetic basis for clinical response to CTLA-4 blockade in melanoma. N Engl J Med (2014) 16.83

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol (2013) 16.13

Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol (2012) 14.01

A landscape of driver mutations in melanoma. Cell (2012) 12.61

A survey of telomerase activity in human cancer. Eur J Cancer (1997) 10.84

Highly recurrent TERT promoter mutations in human melanoma. Science (2013) 8.40

TERT promoter mutations in familial and sporadic melanoma. Science (2013) 7.82

Melanoma genome sequencing reveals frequent PREX2 mutations. Nature (2012) 7.77

Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol (2006) 7.76

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet (2012) 7.00

TopHat-Fusion: an algorithm for discovery of novel fusion transcripts. Genome Biol (2011) 6.23

Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics (2012) 5.04

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science (2015) 4.88

Genomic Classification of Cutaneous Melanoma. Cell (2015) 3.91

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma. Cell (2016) 2.65

TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma. J Natl Cancer Inst (2014) 2.29

PAK signalling during the development and progression of cancer. Nat Rev Cancer (2014) 2.21

Whole genome sequencing of matched primary and metastatic acral melanomas. Genome Res (2011) 1.90

Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch Dermatol (2009) 1.82

Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res (2002) 1.78

Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res (2001) 1.73

P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanoma. J Natl Cancer Inst (2013) 1.68

UV signature mutations. Photochem Photobiol (2014) 1.52

Meta-analysis combining new and existing data sets confirms that the TERT-CLPTM1L locus influences melanoma risk. J Invest Dermatol (2011) 1.14

Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs. BMC Genomics (2013) 1.13

dbSUPER: a database of super-enhancers in mouse and human genome. Nucleic Acids Res (2015) 1.02

Prognosis of acral melanoma: a series of 281 patients. Ann Surg Oncol (2013) 1.00

GAB2 amplifications refine molecular classification of melanoma. Clin Cancer Res (2009) 0.97

The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis. Pigment Cell Melanoma Res (2014) 0.95

SEA: a super-enhancer archive. Nucleic Acids Res (2015) 0.89

Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. Hum Genet (2014) 0.89

Genetic variations in the TERT and CLPTM1L gene region and gastrointestinal stromal tumors risk. Oncotarget (2015) 0.88

Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas. Melanoma Res (2016) 0.86

Long insert whole genome sequencing for copy number variant and translocation detection. Nucleic Acids Res (2013) 0.86

TERT promoter mutation is uncommon in acral lentiginous melanoma. J Cutan Pathol (2014) 0.85

Clinical Activity of Ipilimumab in Acral Melanoma: A Retrospective Review. Oncologist (2015) 0.83

Quantitative assessment of telomerase components in cancer cell lines. FEBS Lett (2015) 0.83

The genomic landscape of cutaneous melanoma. Pigment Cell Melanoma Res (2016) 0.82

Association of genetic polymorphisms in TERT-CLPTM1L with lung cancer in a Chinese population. Genet Mol Res (2015) 0.81

A GWAS Meta-analysis and Replication Study Identifies a Novel Locus within CLPTM1L/TERT Associated with Nasopharyngeal Carcinoma in Individuals of Chinese Ancestry. Cancer Epidemiol Biomarkers Prev (2015) 0.78

A Pharmacological Chaperone Molecule Induces Cancer Cell Death by Restoring Tertiary DNA Structures in Mutant hTERT Promoters. J Am Chem Soc (2016) 0.77